PCI Biotech Invites Stakeholders to Join Presentation
PCI Biotech (OSE: PCIB) is inviting interested parties to take part in a webcast presentation of its interim report for the first half of 2024. This session is set for the morning and will provide valuable insights into the company's latest developments and financial results.
Webcast Presentation Details
The live presentation is scheduled for a specific day, running from 08:30 AM to 09:00 AM CEST. Attendees can access the presentation via the official PCI Biotech website. The session will be conducted in Norwegian and will include an interactive Q&A segment, allowing participants to submit their questions in writing through the provided console.
How to Access the Interim Report and Presentation
Both the interim report and the related presentation materials will be available at the start of the day on the same day as the webcast. Interested individuals can find these documents on the dedicated news portal as well as on the company's website.
About PCI Biotech and Its Areas of Focus
PCI Biotech is committed to driving innovation in the biopharmaceutical industry, focusing on the development and commercialization of cutting-edge technologies and therapies based on its photochemical technology platform. This platform, grounded in advanced research, holds promise for various therapeutic applications.
Photochemical Lysis (PCL)
The PCL technology is designed to induce selective light-triggered cell lysis. This novel approach has the potential to significantly improve the yield and purity in the production of viral vectors, which are essential for gene therapy and vaccine development.
Photochemical Internalization (PCI)
PCI enables the light-triggered release of therapeutic agents from endosomes. This feature aims to enhance the effectiveness and delivery of treatments across a range of medical fields, unlocking the potential of various therapeutic modalities.
Contact Information
For further inquiries or more information regarding the webcast and interim report, stakeholders can reach out to:
Ronny Skuggedal, CEO / CFO
Email: rs@pcibiotech.no
Mobile: +47 9400 5757
Frequently Asked Questions
What is the purpose of the PCI Biotech webcast presentation?
The webcast is designed to provide stakeholders with insights into the company's interim performance and future plans.
When will the presentation take place?
The presentation is set for a morning session, from 08:30 AM to 09:00 AM CEST.
Where can I find the interim report and presentation materials?
The interim report and presentation materials will be accessible through the PCI Biotech website and a dedicated news portal.
In which language will the presentation be conducted?
The presentation will be held in Norwegian.
How can I take part in the Q&A session?
Participants can submit their written questions via the webcast console during the Q&A session at the conclusion of the presentation.
